Epigenetic modulation on tau phosphorylation in Alzheimer's disease

20Citations
Citations of this article
75Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Tau hyperphosphorylation is a typical pathological change in Alzheimer's disease (AD) and is involved in the early onset and progression of AD. Epigenetic modification refers to heritable alterations in gene expression that are not caused by direct changes in the DNA sequence of the gene. Epigenetic modifications, such as noncoding RNA regulation, DNA methylation, and histone modification, can directly or indirectly affect the regulation of tau phosphorylation, thereby participating in AD development and progression. This review summarizes the current research progress on the mechanisms of epigenetic modification associated with tau phosphorylation.

Cite

CITATION STYLE

APA

Yu, C. C., Jiang, T., Yang, A. F., Du, Y. J., Wu, M., & Kong, L. H. (2019). Epigenetic modulation on tau phosphorylation in Alzheimer’s disease. Neural Plasticity. Hindawi Limited. https://doi.org/10.1155/2019/6856327

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free